Ashkan Pourabhari Langroudi M.D.
@ashkanpal
Followers
316
Following
2K
Statuses
64
MD / Urology researcher @Stanford -interested in History, Movies, new Technologies, and Sports- @TehUofMed alumni -Like/Retweet/Follow≠Endorsement -Views My Own
Palo Alto, CA
Joined October 2020
@FarshadSheybaee @uwurology @Hoomandjaladat @siadaneshmand @alirezaghoreifi @USC_Urology Many congratulations, Farshad!
0
0
2
RT @DrMEisenberg: Thank you to @JillC_Buckley for joining @StanfordUrology as Fenmore Visiting Professor. Great talks and great insight int…
0
3
0
@psli2005 @AlbertSHa329 @DrMEisenberg @StanfordUrology @WCMUrology @WeillCornell Congrats, Albert! You are inspiring. Wishing you continued success!
0
0
1
RT @ZahraShokriV: Finally had the chance to meet @MarkMamloukMD in person! Not only is he incredibly knowledgeable🤩, but he’s also kind, fr…
0
3
0
@AlbertSHa329 @DrMEisenberg @StanfordUrology Thank you so much Albert! Hope to catch up soon, maybe in Vegas? 😊
0
0
1
0
0
1
@TowfikSebai @DrMEisenberg @StanfordUrology Thank you so much! Congrats to you too on your accepted abstracts!
0
0
0
RT @AlbertSHa329: Persistence pays off with the best mentor and team. Updates on contemporary vasectomy failure rates in the United States…
0
3
0
📊 Over 489k vasectomized men studied! #Vasectomy failure rates are higher without post-vasectomy semen analysis (PVSA) (+16%). Partner's age & later procedure years lower failure odds. Non-urologist-performed vasectomies = higher repeat rates. (56% higher odds) #MensHealth
0
0
4
RT @ZahraShokriV: Grateful for the chance to share the hard work of our team @PedsMIPS on Image-Guided Glioblastoma Therapy at #RSNA2024 !…
0
5
0
0
0
0
RT @ZahraShokriV: Thrilled to present our work at @rsna today! Thank you to everyone who stopped by and asked great questions! Huge thanks…
0
5
0
RT @ZahraShokri9096: Had a fantastic time presenting at the symposium today! 🎤 Excited to share my work on glioblastoma🧠 and grateful for t…
0
3
0
RT @ZahraShokri9096: Today, I received my ECFMG certification🤓, a milestone that means so much more than just a piece of paper. And on the…
0
2
0
0
0
1
0
0
0
Our study evaluates the strengths and limitations of the FDA's FAERS database in identifying adverse drug events post-market. We highlight its critical role in drug safety surveillance while discussing areas for improvement in contemporary research. @sexmedjournals @StanfordMed
0
0
3